🔎 Trials Near Me

Home › Chronic Progressive Multiple Sclerosis › Ohio

Pag-aaral pangklinika para sa Chronic Progressive Multiple Sclerosis sa Ohio

6 pag-aaral para sa Chronic Progressive Multiple Sclerosis ang naghahanap ng mga kalahok sa mga site sa Ohio.

Mga Lungsod sa Ohio

Opisyal na teksto ng pag-aaral (English)

A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

  • Local Institution - Site 104, Columbus
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07840326

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  • The Ohio State University Wexner Medical Center (OSUWMC), Columbus
  • The Boster Center for Multiple Sclerosis, Columbus
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07299019

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  • The Ohio State University Wexner Medical Center (OSUWMC) L3-100, Columbus
  • The Boster Center for Multiple Sclerosis, Columbus
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07067463

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

  • University of Cincinnati, Cincinnati
Nagre-recruitPhase 1/2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07477639

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

  • University of Cincinnati (UC) Waddell Center for Multiple Sclerosis, Cincinnati
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland
Nagre-recruitPhase 3
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04047628

Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis

  • Cleveland State University, Cleveland
Nagre-recruit
Edad 22 hanggang 75 · Lahat ng kasarian · Na-update Set 24, 2025 · NCT05964829

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.